China's NMPA grants CanSino Biologics approval for clinical trials of recombinant trivalent poliomyelitis vaccine
Sinovac's tetanus vaccine gets medical body's approval
Regulatory Approval for CNBG’s Rotavirus Vaccine, Rotasiro® by NMPA
China's first domestically developed nine-valent HPV vaccine priced at $70 per dose
Hepatitis vaccine gets thumbs up from China's health regulators
Biological E to make HPV9 vaccine under licensing pact with Recbio
Scan the QR code to follow
us on WeChat
京公网安备 11010802041931号 © 2024 cpivc.com